Clinical Trial Update: A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AMG 706 or Bevacizumab in combination with Paclitaxel for breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Locally Recurrent and Metastatic Breast Cancer

Drugs mentioned

• AMG 706 (motesanib)
• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Amgen | Conditions: Breast Neoplasms, Breast Tumors | Phase 2 | Status: TERMINATED